GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.040
-0.100 (-3.18%)
Jul 21, 2026, 11:42 AM EDT - Market open
GoodRx Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 235.71 | 261.82 | 448.35 | 672.3 | 757.17 | 941.11 |
Cash & Short-Term Investments | 235.71 | 261.82 | 448.35 | 672.3 | 757.17 | 941.11 |
Cash Growth | -21.69% | -41.60% | -33.31% | -11.21% | -19.55% | -2.85% |
Accounts Receivable | 232.72 | 235.75 | 145.93 | 143.61 | 117.14 | 118.08 |
Other Current Assets | 798.04 | 145.54 | 64.98 | 56.89 | 45.38 | 29.64 |
Total Current Assets | 1,266 | 643.1 | 659.26 | 872.79 | 919.69 | 1,089 |
Net Property, Plant & Equipment | 40.49 | 41.08 | 40.46 | 45.86 | 55.73 | 49.32 |
Other Intangible Assets | 201.36 | 203.34 | 176.88 | 156.34 | 189.94 | 133.78 |
Goodwill | - | - | - | 410.77 | 412.12 | 329.7 |
Other Long-Term Assets | 82.6 | 86.21 | 100.7 | 103.04 | 27.17 | 6.01 |
Total Assets | 2,021 | 1,404 | 1,388 | 1,589 | 1,605 | 1,608 |
Accounts Payable | 14.53 | 19.41 | 14.14 | 36.27 | 17.7 | 17.5 |
Accrued Expenses | 83.72 | 86.71 | 83.33 | 71.33 | 47.52 | 50.73 |
Current Portion of Long-Term Debt | 5 | 5 | 5 | 8.79 | 7.03 | 7.03 |
Current Portion of Leases | 4.98 | 4.75 | 5.64 | 6.18 | 4.07 | 5.85 |
Other Current Liabilities | 750.98 | 130.14 | 15.8 | - | - | - |
Total Current Liabilities | 859.2 | 246 | 123.9 | 122.56 | 76.32 | 81.11 |
Long-Term Debt | 482.42 | 483.26 | 486.71 | 647.7 | 651.8 | 655.86 |
Long-Term Leases | 48.95 | 49.79 | 46.04 | 48.4 | 54.13 | 33.59 |
Other Long-Term Liabilities | 8.69 | 8.74 | 6.76 | 8.18 | 7.56 | 5.38 |
Total Long-Term Liabilities | 540.07 | 541.79 | 539.51 | 704.28 | 713.48 | 694.83 |
Total Liabilities | 1,399 | 787.8 | 663.41 | 826.84 | 789.8 | 775.95 |
Common Stock | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
Additional Paid-in Capital | 2,031 | 2,027 | 2,166 | 2,219 | 2,263 | 2,247 |
Retained Earnings | -1,409 | -1,411 | -1,441 | -1,457 | -1,449 | -1,416 |
Shareholders' Equity | 621.99 | 616.26 | 724.66 | 761.96 | 814.83 | 831.68 |
Total Liabilities & Equity | 2,021 | 1,404 | 1,388 | 1,589 | 1,605 | 1,608 |
Total Debt | 541.35 | 542.81 | 543.39 | 711.07 | 717.02 | 702.33 |
Net Cash (Debt) | -305.64 | -280.99 | -95.04 | -38.77 | 40.14 | 238.78 |
Net Cash Growth | - | - | - | - | -83.19% | -9.47% |
Net Cash Per Share | -0.88 | -0.79 | -0.24 | -0.09 | 0.10 | 0.58 |
Book Value | 621.99 | 616.26 | 724.66 | 761.96 | 814.83 | 831.68 |
Book Value Per Share | 1.79 | 1.73 | 1.85 | 1.86 | 1.97 | 2.03 |
Tangible Book Value | 420.63 | 412.92 | 547.78 | 194.85 | 212.77 | 368.21 |
Tangible Book Value Per Share | 1.21 | 1.16 | 1.40 | 0.47 | 0.52 | 0.90 |